Osama A. Badary

4.5k total citations
92 papers, 3.6k citations indexed

About

Osama A. Badary is a scholar working on Complementary and alternative medicine, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Osama A. Badary has authored 92 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Complementary and alternative medicine, 22 papers in Molecular Biology and 21 papers in Pathology and Forensic Medicine. Recurrent topics in Osama A. Badary's work include Nigella sativa pharmacological applications (24 papers), Chemotherapy-induced organ toxicity mitigation (17 papers) and Bioactive Compounds and Antitumor Agents (8 papers). Osama A. Badary is often cited by papers focused on Nigella sativa pharmacological applications (24 papers), Chemotherapy-induced organ toxicity mitigation (17 papers) and Bioactive Compounds and Antitumor Agents (8 papers). Osama A. Badary collaborates with scholars based in Egypt, United States and Saudi Arabia. Osama A. Badary's co-authors include Ayman M. Gamal El-Din, Mahmoud N. Nagi, MOHAMED H. ABDEL-WAHAB, Othman A. Al‐Shabanah, Abdullah M. Al‐Bekairi, Farid M.A. Hamada, Ragia A. Taha, Mohamed M. Elmazar, Ashraf B. Abdel‐Naim and Sahar M. Abdel-Maksoud and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Free Radical Biology and Medicine.

In The Last Decade

Osama A. Badary

90 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Osama A. Badary Egypt 34 1.8k 778 729 727 655 92 3.6k
Othman A. Al‐Shabanah Saudi Arabia 40 1.2k 0.6× 446 0.6× 1.0k 1.4× 891 1.2× 719 1.1× 118 4.3k
Abul Kalam Najmi India 37 1.5k 0.8× 293 0.4× 1.2k 1.6× 451 0.6× 693 1.1× 225 5.3k
Ömer Küçük United States 46 565 0.3× 244 0.3× 2.3k 3.1× 1.3k 1.8× 304 0.5× 206 6.8k
Seyed Jalal Hosseinimehr Iran 38 593 0.3× 142 0.2× 1.6k 2.1× 351 0.5× 350 0.5× 225 5.6k
Veerapol Kukongviriyapan Thailand 40 385 0.2× 110 0.1× 1.5k 2.0× 253 0.3× 407 0.6× 147 4.0k
Kan He United States 41 424 0.2× 147 0.2× 1.9k 2.6× 203 0.3× 1.3k 2.0× 109 5.8k
Hye Hyun Yoo South Korea 30 310 0.2× 191 0.2× 1.5k 2.0× 175 0.2× 651 1.0× 161 3.0k
Keizo Umegaki Japan 38 800 0.4× 48 0.1× 1.0k 1.4× 1.1k 1.4× 580 0.9× 225 5.0k
Hye Suk Lee South Korea 39 304 0.2× 221 0.3× 2.4k 3.3× 152 0.2× 935 1.4× 254 5.1k
Yu‐Chi Hou Taiwan 36 456 0.3× 108 0.1× 1.2k 1.6× 203 0.3× 946 1.4× 115 3.3k

Countries citing papers authored by Osama A. Badary

Since Specialization
Citations

This map shows the geographic impact of Osama A. Badary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Osama A. Badary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Osama A. Badary more than expected).

Fields of papers citing papers by Osama A. Badary

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Osama A. Badary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Osama A. Badary. The network helps show where Osama A. Badary may publish in the future.

Co-authorship network of co-authors of Osama A. Badary

This figure shows the co-authorship network connecting the top 25 collaborators of Osama A. Badary. A scholar is included among the top collaborators of Osama A. Badary based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Osama A. Badary. Osama A. Badary is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Salama, Maha M., et al.. (2024). The Potential of Natural Products in the Management of COVID-19. Advances in experimental medicine and biology. 215–235.
3.
Zaki, Hala F., et al.. (2024). Efficacy and Toxicity of Vincristine and CYP3A5 Genetic Polymorphism in Rhabdomyosarcoma Pediatric Egyptian Patients. Asian Pacific Journal of Cancer Prevention. 25(4). 1391–1409. 2 indexed citations
4.
Badary, Osama A., et al.. (2023). A comprehensive review on lipid nanocarrier systems for cancer treatment: fabrication, future prospects and clinical trials. Journal of Liposome Research. 34(1). 135–177. 10 indexed citations
5.
Badary, Osama A.. (2023). Implications of potential clinically relevant interactions between COVID‐19 vaccines and concomitant medications. Reviews in Medical Virology. 33(3). e2417–e2417. 1 indexed citations
8.
Attia, Yasmin M., et al.. (2022). Thymoquinone Suppresses Angiogenesis in DEN-Induced Hepatocellular Carcinoma by Targeting miR-1-3p. International Journal of Molecular Sciences. 23(24). 15904–15904. 13 indexed citations
10.
Badary, Osama A., et al.. (2021). Thymoquinone: A Promising Natural Compound with Potential Benefits for COVID-19 Prevention and Cure. Drug Design Development and Therapy. Volume 15. 1819–1833. 54 indexed citations
11.
Hamza, Marwa S., Osama A. Badary, & Mohamed M. Elmazar. (2020). Cross-Sectional Study on Awareness and Knowledge of COVID-19 Among Senior pharmacy Students. Journal of Community Health. 46(1). 139–146. 61 indexed citations
12.
Elkafas, Hoda, et al.. (2019). Targeting activated pro-inflammatory pathway in primed myometrial stem cells with vitamin D3 and Paricalcitol. Fertility and Sterility. 112(3). e100–e101. 3 indexed citations
13.
El‐Maraghy, Nabila N., et al.. (2018). Protective effects of thymoquinone on D-galactose and aluminum chloride induced neurotoxicity in rats: biochemical, histological and behavioral changes. Neurological Research. 40(4). 324–333. 45 indexed citations
14.
Langaee, Taimour, et al.. (2016). Identification of Suitable Endogenous Normalizers for qRT-PCR Analysis of Plasma microRNA Expression in Essential Hypertension. Molecular Biotechnology. 58(3). 179–187. 39 indexed citations
15.
El‐Shenawy, Siham M., et al.. (2013). Study of the effect of Allium porrum on osteoporosis induced in rats. Der pharmacia lettre. 5(1). 188–198. 5 indexed citations
16.
Badary, Osama A., et al.. (2013). Study of the effect of Allium porrum on hypertension induced in rats. Revista latinoamericana de química. 41(3). 149–160. 11 indexed citations
18.
Badary, Osama A., et al.. (2011). Reducing prescribing errors in the paediatric intensive care unit: an experience from Egypt. Acta Paediatrica. 100(10). 39 indexed citations
19.
Badary, Osama A., et al.. (2009). 1071 Nigella sativa L. oil ameliorates methotrexate-induced intestinal toxicity through antioxidant activity. European Journal of Cancer Supplements. 7(2). 106–106. 1 indexed citations
20.
Badary, Osama A., et al.. (2003). Effects of benzo[a]pyrene on tissue activities of metabolizing enzymes and antioxidant system in normal and protein‐malnourished rats. Journal of Biochemical and Molecular Toxicology. 17(2). 86–91. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026